Sign Up to like & get
recommendations!
1
Published in 2021 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.937
Abstract: Dabrafenib is an oral BRAF kinase inhibitor approved for the treatment of various BRAF V600 mutation–positive solid tumors. In vitro observations suggesting cytochrome P450 (CYP) 3A induction and organic anion transporting polypeptide (OATP) inhibition prompted…
read more here.
Keywords:
oatp1b1 1b3;
1b3 substrate;
midazolam;
time ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2584
Abstract: This study was designed to assess the quantitative performance of endogenous biomarkers for organic anion transporting polypeptide (OATP) 1B1/1B3‐mediated drug‐drug interactions (DDIs). Ten healthy volunteers orally received OATP1B1/1B3 probe cocktail (0.2 mg pitavastatin, 1 mg…
read more here.
Keywords:
drug interactions;
oatp1b1 1b3;
pitavastatin;
cysa ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-20815-1
Abstract: Organic Anion-Transporting Polypeptides are multispecific membrane proteins that regulate the passage of crucial endobiotics and drugs across pharmacological barriers. OATP1B1 and OATP1B3 have been described to play a major role in the hepatic uptake of…
read more here.
Keywords:
1b3 2b1;
oatp1b1 1b3;
transporting polypeptides;
anion transporting ... See more keywords